Trial intelligence / Profile preview

Characterisation of maximum actinic keratosis lesions count during Imiquimod 3.75% treatment by HD-OCT and RCM

2013-005546-11Phase 3Completed

Sponsor

University of Modena and Reggio Emilia

Start

Apr 2014

Modality

Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1